Shatavisa Mukherjee

11PUBLICATIONS
16CO-AUTHORS
Pharmaceutical delivery technologiesMajor global burdens of diseaseCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 08, 2026
Dulaglutide in the era of tirzepatide and semaglutide: reaffirming its role in contemporary cardiometabolic care.

|Mar 14, 2026
Equity in Pharmacovigilance: The Role of Health Literacy in Centering Marginalized Patient Voices.

Shatavisa Mukherjee

|Feb 16, 2026
GLP-1 receptor agonists and smoking cessation: therapeutic promise beyond glycemia.

Gaurab Bhaduri, Shatavisa Mukherjee, Rakesh Parikh

|Jan 08, 2026
Decoupling weight loss from organoprotective benefits in GLP-1RA, dual agonists, and SGLT2I therapy: A narrative review.

Gaurab Bhaduri, Supratik Bhattacharyya, Shatavisa Mukherjee

|Dec 10, 2025
Effectiveness and safety of saroglitazar in managing dyslipidaemia and liver enzymes in patients with type 2 diabetes, MASLD, and Stage 3 chronic kidney disease: A 12-month observational study.

Gaurab Bhaduri, Shambo S Samajdar, Sanjay Bandyopadhyay

|Nov 10, 2025
Quetiapine Extended-Release and Peripheral Edema: A Case Report and Literature Review.

Seshadri Sekhar Chatterjee, Shatavisa Mukherjee, Soumitra Das

Pageof 2

Frequent Collaborators

3 joint publications

Shambo Samrat Samajdar

3 joint publications

Gaurab Bhaduri

2 joint publications

Saibal Das

2 joint publications

Ashish Pathak